Maternus-Kliniken Aktiengesellschaft

Symbol: MAK.DE




Market price today

  • -2.0053

    P/E Ratio

  • 0.0084

    PEG Ratio

  • 49.49M

    MRK Cap

  • 0.00%

    DIV Yield

Maternus-Kliniken Aktiengesellschaft (MAK-DE) Stock Price & Analysis

Shares Outstanding


Gross Profit Margin


Operating Profit Margin


Net Profit Margin


Return on Assets


Return on Equity


Return on Capital Employed


Company general description and statistics

Sector: Healthcare
Industry: Medical Care Facilities
CEO:Mr. Mario Augusto Ruano Wohlers
Full-time employees:1480
Address:FranzOesische Strasse 53 - 55

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.

General Outlook

When we look at how much money they make before expenses, they keep 0.257% as profit. This shows they're good at controlling costs and are financially stable. Their operating profit, which is money made from regular business activities, is -0.113%. This means they run their business efficiently. Lastly, after paying all their bills, they still have a profit of -0.171%. This tells us they're good at keeping money after all costs.

Return on Investments

The company's asset efficiency, represented by a robust -0.113% return, is a testament to Maternus-Kliniken Aktiengesellschaft's adeptness in optimizing resource deployment. Maternus-Kliniken Aktiengesellschaft's utilization of its assets to generate profits is strikingly evident through a noteworthy return on equity of 0.420%. Furthermore, the proficiency of Maternus-Kliniken Aktiengesellschaft in capital utilization is underscored by a remarkable -0.136% return on capital employed.

Stock Prices

Maternus-Kliniken Aktiengesellschaft's stock prices have been subject to undulating patterns. The peak stock value during this interval surged to $2.26, while its low point bottomed out at $2.26. This variance in figures offers investors a lucid insight into the roller-coaster ride that is Maternus-Kliniken Aktiengesellschaft's stock market.

Liquidity Ratios

Analyzing MAK.DE liquidity ratios reveals its financial health of the firm. The current ratio of 32.61% gauges short-term asset coverage for liabilities. The quick ratio (31.21%) assesses immediate liquidity, while the cash ratio (6.04%) indicates cash reserves.

Current Ratio32.61%
Quick Ratio31.21%
Cash Ratio6.04%

Profitability Ratios

MAK.DE profitability indicators offer a lens into its earnings landscape. A pretax profit margin of -18.15% underscores its earnings before tax deductions. The effective tax rate stands at -6.68%, revealing its tax efficiency. The net income per EBT, 94.44%, and the EBT per EBIT, 161.26%, provide insights into its earnings hierarchy. Lastly, with an EBIT per revenue ratio of -11.25%, we grasp its operational profitability.

Pretax Profit Margin-18.15%
Effective Tax Rate-6.68%
Net Income per EBT94.44%
EBT per EBIT161.26%
EBIT per Revenue-11.25%

Operational Efficiency

Operational metrics shed light on its business agility. With an operating cycle of 0.33, it details the span from stock purchase to revenue.

Days of Sales Outstanding31
Days of Inventory Outstanding3
Operating Cycle25.94
Days of Payables Outstanding23
Cash Conversion Cycle3
Receivables Turnover15.78
Payables Turnover15.86
Inventory Turnover129.94
Fixed Asset Turnover0.87
Asset Turnover0.66

Cash Flow Ratios

Peering into the cash flow metrics reveals liquidity and operational efficiency. The operating cash flow per share, -0.41, and free cash flow per share, -0.52, depict cash generation on a per-share basis. The cash per share value, 0.75, showcases liquidity position. Lastly, the operating cash flow sales ratio, -0.08, offers insight into cash flow relative to sales.

Operating Cash Flow per Share-0.41
Free Cash Flow per Share-0.52
Cash per Share0.75
Operating Cash Flow Sales Ratio-0.08
Free Cash Flow to Operating Cash Flow Ratio1.28
Cash Flow Coverage Ratio-0.05
Short Term Coverage Ratio-0.16
Capital Expenditure Coverage Ratio-3.53
Dividend Paid and Capex Coverage Ratio-3.53

Debt and Leverage Ratios

Diving into debt and leverage metrics unveils the company's financial structure. The debt ratio, at 117.52%, highlights its total liabilities relative to assets. With a debt-equity ratio of -3.77, we discern the balance between debt and equity financing. The long-term debt to capitalization, 159.21%, and total debt to capitalization, 136.06%, ratios shed light on its capital structure. An interest coverage of -2.13 indicates its ability to manage interest expenses.

Debt Ratio117.52%
Debt Equity Ratio-3.77
Long Term Debt to Capitalization159.21%
Total Debt to Capitalization136.06%
Interest Coverage-2.13
Cash Flow to Debt Ratio-0.05
Company Equity Multiplier-3.21

Per Share Data

Speaking about the per share data offers a perceptive view of financial distribution. The revenue per share, 5.09, provides a glimpse into top-line earnings distributed across each share. Net income per share, -0.67, reflects the portion of profit attributed to each share. The book value per share, -1.87, represents the net asset value distributed per share, while the tangible book value per share, -2.51, excludes intangible assets.

Revenue Per Share5.09
Net Income Per Share-0.67
Book Value Per Share-1.87
Tangible Book Value Per Share-2.51
Shareholders Equity Per Share-1.87
Interest Debt Per Share8.40
Capex Per Share-0.10

Growth Ratios

Delving into growth metrics provides a snapshot of financial expansion. The revenue growth rate, -4.25%, indicates top-line expansion, while the gross profit growth, -10.81%, reveals profitability trends. EBIT growth, -293.85%, and operating income growth, -293.85%, offer insights into operational profitability progression. The net income growth, -466.48%, showcases bottom-line expansion, and the EPS growth, -458.33%, measures the growth in earnings per share.

Revenue Growth-4.25%
Gross Profit Growth-10.81%
EBIT Growth-293.85%
Operating Income Growth-293.85%
Net Income Growth-466.48%
EPS Growth-458.33%
EPS Diluted Growth-458.33%
Operating Cash Flow Growth-74.90%
Free Cash Flow Growth-84.82%
10-Year Revenue Growth per Share-6.36%
5-Year Revenue Growth per Share-16.08%
3-Year Revenue Growth per Share-14.25%
10-Year Operating CF Growth per Share-1.21%
5-Year Operating CF Growth per Share-37.46%
3-Year Operating CF Growth per Share-72.99%
10-Year Net Income Growth per Share-63.71%
5-Year Net Income Growth per Share-866.83%
3-Year Net Income Growth per Share-37.26%
10-Year Shareholders Equity Growth per Share-99.86%
5-Year Shareholders Equity Growth per Share-929.04%
3-Year Shareholders Equity Growth per Share-148.13%
Receivables Growth30.54%
Inventory Growth-2.01%
Asset Growth-7.26%
Book Value per Share Growth-41.12%
Debt Growth0.78%
SGA Expenses Growth-3.33%

Other Metrics

Venturing into other key metrics unveils diverse facets of financial performance. The enterprise value, 203,063,200, captures the company's total value, considering both debt and equity. Income quality, -0.34, assesses the reliability of reported earnings. The ratio of intangibles to total assets, 8.67%, indicates the value of non-physical assets, and capex to operating cash flow, -46.27%, measures reinvestment capability.

Enterprise Value203,063,200
Income Quality-0.34
Sales General and Administrative to Revenue0.03
Intangibles to Total Assets8.67%
Capex to Operating Cash Flow-46.27%
Capex to Revenue-1.88%
Capex to Depreciation-18.18%
Graham Number5.32
Return on Tangible Assets-10.05%
Graham Net Net-8.53
Working Capital-39,439,000
Tangible Asset Value-52,606,000
Net Current Asset Value-175,808,000
Invested Capital-4
Average Receivables9,810,500
Average Payables5,653,500
Average Inventory592,000
Days Sales Outstanding38
Days Payables Outstanding107
Days of Inventory On Hand11

Valuation Ratios

Exploring the valuation ratios offers insights into perceived market value. The price to book value ratio, -0.73, and the price to book ratio, -0.73, reflect the market's valuation relative to the company's book value. The price to sales ratio, 0.34, provides a perspective on valuation in relation to sales. Ratios like price to free cash flows, -3.22, and price to operating cash flows, -4.13, gauge market valuation against cash flow metrics.

Price Book Value Ratio-0.73
Price to Book Ratio-0.73
Price to Sales Ratio0.34
Price Cash Flow Ratio-4.13
Price Earnings to Growth Ratio0.01
Enterprise Value Multiple97.19
Price Fair Value-0.73
Price to Operating Cash Flow Ratio-4.13
Price to Free Cash Flows Ratio-3.22
Price to Tangible Book Ratio-0.89
Enterprise Value to Sales1.90
Enterprise Value Over EBITDA64.02
EV to Operating Cash Flow46.91
Earnings Yield-40.44%
Free Cash Flow Yield6.68%
Trusted project
“All information displayed on the site is verified. High quality project and financial performance”
Eugene Alexeev
NumFin Founder and investing enthusiast

Frequently Asked Question

How many company shares are outstanding in 2024?

There are stock number shares outstanding of Maternus-Kliniken Aktiengesellschaft (MAK.DE) on the XETRA in 2024.

What is P/E ratio of enterprise in 2024?

The current P/E ratio of enterprise is -2.005 in 2024.

What is the ticker symbol of Maternus-Kliniken Aktiengesellschaft stock?

The ticker symbol of Maternus-Kliniken Aktiengesellschaft stock is MAK.DE.

What is company IPO date?

IPO date of Maternus-Kliniken Aktiengesellschaft is 1999-05-21.

What is company current share price?

Current share price is 2.360 EUR.

What is stock market cap today?

The market cap of stock today is 49489200.000.

What is PEG ratio in 2024?

The current 0.008 is 0.008 in 2024.

What is the number of employees in 2024?

In 2024 the company has 1480.